However, Eli Lilly's existing GLP-1 franchise generated $36.5 billion in 2025, analysts project retatrutide could add $15+ billion annually, and the combined obesity drug market is projected to reach $101 billion in peak annual sales
Therefore, if the newborn screening detects low carnitine levels, both the baby and the mother are re-tested, after two weeks, to determine who has PCD.[14] Treatment / Management The mainstay of primary carnitine deficiency involves lifelong treatment with a high dose of oral L-carnitine (100 to 200 mg/kg daily dose in 3 divided doses).[3][4] The oral bioavailability of L-carnitine is 5% to 18%.[5] L-carnitine is a fairly safe medication, and few side effects associated with high doses include diarrhea and intestinal discomfort
Is the prescribing provider an in-person clinician with visibility into your full medical history
Effect of Continued Once-Weekly Semaglutide 2.4 Mg on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Maintenance Trial
Its an opioid, has analgesic effects similar to morphine and can therefore raise the pain threshold